Article Text

Download PDFPDF

PM.16 Ultrasound Colour-Flow Doppler in Initial Assessment of Morbidly Adherent Placenta Followed by Selective MR Imaging: A Case Series
  1. LJ Scarrott,
  2. OA Jibodu,
  3. U Rajesh
  1. York Teaching Hospital, York, UK


Morbidly adherent placenta (MAP) is the abnormal attachment of the placenta to the uterine wall in which trophoblastic cells invade the uterine tissues. MAP is rare, affecting 1 in 2500 pregnancies1, however it is associated with high feto-maternal morbidity and mortality2. Previous caesarean section is a major risk factor for development of MAP3, and complicates 24% of cases of placenta praevia after one prior caesarean section4. With the current trend of increasing caesarean section rates5, MAP will pose significant obstetric problems in the future.

Antenatal diagnosis of MAP has been shown to reduce maternal morbidity6. Recent guidance from the National Institute for Clinical Excellence suggests that in cases where there is suspicion of MAP, colour-flow Doppler ultrasound should be used as a first line diagnostic tool7. Presence of irregular lacunae within the placental architecture and loss of the clear space in the retroplacental plane are considered to be useful diagnostic criteria in ultrasound imaging of MAP8. Where such ultrasound changes are found, magnetic resonance imaging (MRI) can then be considered to confirm diagnosis and evaluate the extent of invasion which would aid management planning6.

We present a case series of 6 patients presenting to York Teaching Hospital in whom MAP was queried on the basis of previous caesarean section, placental localisation scan or clinical presentation. We discuss the role of colour-flow Doppler ultrasound in the initial assessment of suspected MAP followed by selective use of MRI.


  1. Committee on Obstetric Practice. ACOG committee opinion. Placenta Accreta. Number 266, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;77: 77–8.

  2. Centre for Maternal and Child Enquiries (CMACE). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118 (Suppl. 1):1–203.

  3. Placenta accreta: Pathogenesis of a 20th century iatrogenic uterine disease. Jauniaux E, Jurkovic D Placenta, April 2012, vol./is. 33/4(244–51), 1532–3102.

  4. Placenta praevia/accreta and prior caesarean section. Clark SL, Koonings PP, Phelan JP. Obstet Gynecol 1985;66:89–92.

  5. Royal College of Obstetrics and Gynaecology Clinical Effectiveness Support Unit. The national sentinel caesarean section audit report London: RCOG Press, 2001.

  6. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, Kelly TF, Moore TR, Resnik R. Obstet Gynecol. 2010;115(1):65–9.

  7. National Institute for Health and Clinical Excellence 2011. Caesarean Section. CG132. London: National Institute for Health and Clinical Excellence.

  8. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with grey-scale and colour Doppler techniques. Shih JC, Palacios JM, Su YN, Shyu MK, Lin CH, Lin SY, et al, Ultrasound Obstet Gynecol 2009;33:193–203.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.